These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Opioids in patients with COPD and refractory dyspnea: literature review and design of a multicenter double blind study of low dosed morphine and fentanyl (MoreFoRCOPD). van Dijk M; Mooren KJM; van den Berg JK; van Beurden-Moeskops WJC; Heller-Baan R; de Hosson SM; Lam-Wong WY; Peters L; Pool K; Kerstjens HAM BMC Pulm Med; 2021 Sep; 21(1):289. PubMed ID: 34507574 [TBL] [Abstract][Full Text] [Related]
3. Attitudes toward opioids for refractory dyspnea in COPD among Dutch chest physicians. Janssen DJ; de Hosson SM; bij de Vaate E; Mooren KJ; Baas AA Chron Respir Dis; 2015 May; 12(2):85-92. PubMed ID: 25676931 [TBL] [Abstract][Full Text] [Related]
4. Management of refractory breathlessness with morphine in patients with chronic obstructive pulmonary disease. Smallwood N; Le B; Currow D; Irving L; Philip J Intern Med J; 2015 Sep; 45(9):898-904. PubMed ID: 26332621 [TBL] [Abstract][Full Text] [Related]
5. Effect of Sustained-Release Morphine for Refractory Breathlessness in Chronic Obstructive Pulmonary Disease on Health Status: A Randomized Clinical Trial. Verberkt CA; van den Beuken-van Everdingen MHJ; Schols JMGA; Hameleers N; Wouters EFM; Janssen DJA JAMA Intern Med; 2020 Oct; 180(10):1306-1314. PubMed ID: 32804188 [TBL] [Abstract][Full Text] [Related]
6. Opioids for palliation of refractory dyspnea in chronic obstructive pulmonary disease patients. Varkey B Curr Opin Pulm Med; 2010 Mar; 16(2):150-4. PubMed ID: 20071992 [TBL] [Abstract][Full Text] [Related]
7. Perceptions on Use of Opioids in Palliative Care of Dyspnoea in Patients with Fibrotic interstitial lung disease and Chronic Obstructive Pulmonary Disease: A Qualitative Study. Hvelplund CY; Refsgaard B; Bendstrup E Am J Hosp Palliat Care; 2024 Nov; 41(11):1322-1328. PubMed ID: 38326740 [TBL] [Abstract][Full Text] [Related]
8. A randomized controlled trial on the benefits and respiratory adverse effects of morphine for refractory dyspnea in patients with COPD: Protocol of the MORDYC study. Verberkt CA; van den Beuken-van Everdingen MH; Franssen FM; Dirksen CD; Schols JM; Wouters EF; Janssen DJ Contemp Clin Trials; 2016 Mar; 47():228-34. PubMed ID: 26825021 [TBL] [Abstract][Full Text] [Related]
9. Perspectives of patients, family caregivers and physicians about the use of opioids for refractory dyspnea in advanced chronic obstructive pulmonary disease. Rocker G; Young J; Donahue M; Farquhar M; Simpson C CMAJ; 2012 Jun; 184(9):E497-504. PubMed ID: 22529167 [TBL] [Abstract][Full Text] [Related]
10. Palliation of dyspnoea in advanced COPD: revisiting a role for opioids. Rocker G; Horton R; Currow D; Goodridge D; Young J; Booth S Thorax; 2009 Oct; 64(10):910-5. PubMed ID: 19786716 [TBL] [Abstract][Full Text] [Related]
11. The role of benzodiazepines in breathlessness: a single site, open label pilot of sustained release morphine together with clonazepam. Allcroft P; Margitanovic V; Greene A; Agar MR; Clark K; Abernethy AP; Currow DC J Palliat Med; 2013 Jul; 16(7):741-4. PubMed ID: 23597092 [TBL] [Abstract][Full Text] [Related]
13. Junior doctors' attitudes to opioids for refractory breathlessness in patients with advanced chronic obstructive pulmonary disease. Smallwood N; Gaffney N; Gorelik A; Irving L; Le B; Philip J Intern Med J; 2017 Sep; 47(9):1050-1056. PubMed ID: 28585274 [TBL] [Abstract][Full Text] [Related]
14. Barriers to Prescribing Opioids in the Management of Chronic Breathlessness in COPD: A Review. Keogh E; Williams EM COPD; 2021 Dec; 18(6):713-722. PubMed ID: 34761726 [TBL] [Abstract][Full Text] [Related]
15. Opioid utility for dyspnea in chronic obstructive pulmonary disease: a complicated and controversial story. Vozoris NT Ann Palliat Med; 2020 Mar; 9(2):571-578. PubMed ID: 31865744 [TBL] [Abstract][Full Text] [Related]
16. Nebulized morphine for the relief of dyspnea. Mabe SR; Connelly JF Am J Health Syst Pharm; 1995 Jan; 52(2):146-8. PubMed ID: 12879541 [No Abstract] [Full Text] [Related]
17. Using opioids to treat dyspnea in advanced COPD: attitudes and experiences of family physicians and respiratory therapists. Young J; Donahue M; Farquhar M; Simpson C; Rocker G Can Fam Physician; 2012 Jul; 58(7):e401-7. PubMed ID: 22798476 [TBL] [Abstract][Full Text] [Related]
18. Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: a Canadian Thoracic Society clinical practice guideline. Marciniuk DD; Goodridge D; Hernandez P; Rocker G; Balter M; Bailey P; Ford G; Bourbeau J; O'Donnell DE; Maltais F; Mularski RA; Cave AJ; Mayers I; Kennedy V; Oliver TK; Brown C; Can Respir J; 2011; 18(2):69-78. PubMed ID: 21499589 [TBL] [Abstract][Full Text] [Related]
19. Palliative management of refractory dyspnea in COPD. Uronis HE; Currow DC; Abernethy AP Int J Chron Obstruct Pulmon Dis; 2006; 1(3):289-304. PubMed ID: 18046866 [TBL] [Abstract][Full Text] [Related]
20. A Palliative Approach is Adopted for Many Patients Dying in Hospital with Chronic Obstructive Pulmonary Disease. Smallwood N; Ross L; Taverner J; John J; Baisch A; Irving L; Philip J COPD; 2018 Oct; 15(5):503-511. PubMed ID: 30822239 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]